Next-Generation Sequencing (NGS) Corneal Dystrophy Panel in UAE | 3200 AED | 2026 DHA Guidelines

تحليل لوحة ضمور القرنية بتسلسل الجيل التالي (NGS) في الإمارات | 3200 درهم | معتمد من هيئة الصحة بدبي

Executive Summary

Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited NGS processing with Sanger confirmation.
Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy.
Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by genetic specialists.
Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.

الملخص التنفيذي

دقة تشخيصية تصل إلى 99.9% من خلال تقنية تسلسل الجيل التالي المعتمدة وفق معايير الآيزو. خدمة سحب الدم المنزلي المتميزة مع نقل بارد حسب بروتوكول المستشفيات، وإرشاد طبي هاتفي بعد النتيجة. دعم التحقق المباشر من التغطية التأمينية عبر الواتساب.

Overview

The NGS Corneal Dystrophy Panel simultaneously analyzes all known genes linked to hereditary corneal dystrophies, delivering a definitive molecular diagnosis. تتيح لوحة الفحص الجيني الشامل لضمور القرنية تشخيصاً جزيئياً دقيقاً لجميع الأنماط الوراثية. This test is the gold standard for confirming clinical suspicion, guiding surgical decisions, and enabling family risk assessment.

Feature	Our NGS Panel	Single-Gene Sanger Sequencing
Genes Analyzed	All corneal dystrophy genes (e.g., TGFBI, CHST6, COL8A2, etc.)	1 gene (targeted)
Detection Rate	>95% of pathogenic variants	Limited to known hotspots
Turnaround Time	45 working days	30–45 working days
Validation	Every variant confirmed by Sanger sequencing	Sanger only
Price	3200 AED	~2400 AED

Physician Insight & Safety Protocol

“As a DHA-licensed Clinical Pathologist, I emphasize that a positive NGS result must always be interpreted in the context of corneal topography, slit-lamp findings, and family history. A negative result does not exclude non-genetic causes or variants in genes not yet linked to disease. I urge every patient to discuss findings with their ophthalmologist before making any treatment decision.” — Dr. PRABHAKAR REDDY, DHA 61713011

Medication Warning:

Do not discontinue prescribed medication without consulting your doctor. Genetic results do not override ongoing clinical management.

Safety Exclusion Criteria & Emergency Signs

Exclusion: Recent whole blood transfusion or bone marrow transplant (within 6 weeks) – may yield donor DNA. Inability to provide informed consent or mandatory Form 37.
ER Red Flags: Sudden severe eye pain, rapid vision loss, or acute corneal clouding are medical emergencies unrelated to genetic testing; seek immediate ophthalmic care.

Patient FAQ & Clinical Guidance

1. What exactly does the NGS Corneal Dystrophy Panel detect?

Our panel sequences all major genes associated with hereditary corneal dystrophies, identifying pathogenic mutations with high accuracy. تقوم اللوحة بتحليل الجينات المرتبطة بضمور القرنية الوراثي كاملةً، وتكشف الطفرات المسببة للمرض بدقة عالية. This helps classify the specific dystrophy subtype (e.g., granular, lattice, macular) and guides prognostic and therapeutic decisions.

2. How is the blood sample collected for this test in Dubai or Abu Dhabi?

A certified phlebotomist visits your home (8 AM – 11 PM) to draw two 5 mL lavender-top EDTA tubes, which are immediately refrigerated. يقوم فني سحب دم معتمد بزيارة منزلية لسحب عينتين في أنابيب EDTA بنفسجية، مع حفظها مبردة فوراً. The Whole Exome Sequencing Consent Form (Form 37) must be signed before the draw; our team provides the form and guides you through completion.

3. What do my results mean and how are they delivered?

Results are reported as Positive (pathogenic variant found), Negative (no known variant), or Variant of Uncertain Significance (VUS) with expert interpretation. تُقدم النتائج مع تفسير طبي متخصص عبر تقرير إلكتروني ومشورة هاتفية بعد الإصدار. A telephonic post-test counselling session with a genetic specialist is included to explain the clinical implications and next steps.

Regulatory & Accreditation Compliance

This service strictly adheres to Federal Decree-Law No. 41 of 2024 (Art. 87), CDS Law 2026 (Minors), and UAE PDPL. Our facility holds ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) and is licensed by the relevant health authority (Facility License No. 9834453). Pre- Form 37 compliance and genetic confidentiality are maintained at every step.

LOINC code: 93793-3 | ICD-10-CM: H18.5 (Hereditary corneal dystrophy), Z14.8 (Genetic susceptibility).

دعم ثنائي اللغة متاح